| 4826 | It has been a while but I am back. | kaiser | 09/28/2025 5:45:13 PM |
| 3710 | IPRU 0006 X 0007 nice bid in. Looks | kaiser | 04/04/2014 9:51:31 AM |
| 3709 | EHOS 0099 | kaiser | 04/04/2014 9:48:37 AM |
| 3708 | MELY 0035 | kaiser | 04/04/2014 9:43:59 AM |
| 3707 | EHOS 0084 | kaiser | 04/04/2014 9:43:03 AM |
| 3706 | EHOS 008 hitting | kaiser | 04/04/2014 9:40:02 AM |
| 3705 | MELY 0031 X 0032 | kaiser | 04/04/2014 9:25:23 AM |
| 3704 | EHOS 008 X 009 premarket | kaiser | 04/04/2014 9:19:43 AM |
| 3703 | IPRU 0008 | kaiser | 04/03/2014 3:58:38 PM |
| 3702 | EHOS 0074 | kaiser | 04/03/2014 3:56:12 PM |
| 3701 | IPRU 0007 nice hits coming in | kaiser | 04/03/2014 3:55:13 PM |
| 3700 | LGBS 0017 hitting | kaiser | 04/03/2014 3:52:25 PM |
| 3699 | EHOS 007 X 0071 | kaiser | 04/03/2014 3:42:43 PM |
| 3698 | EHOS 007 going | kaiser | 04/03/2014 3:41:04 PM |
| 3697 | MELY 0023 | kaiser | 04/03/2014 3:35:30 PM |
| 3696 | EHOS 007 | kaiser | 04/03/2014 3:34:40 PM |
| 3695 | EHOS 0068 | kaiser | 04/03/2014 3:21:05 PM |
| 3694 | IPRU 0006 like this one here. Bid | kaiser | 04/03/2014 3:15:40 PM |
| 3693 | $TD | PurpleNinjaPanda | 04/03/2014 3:01:57 PM |
| 3692 | LGBS 0016 X 0017 | kaiser | 04/03/2014 2:54:33 PM |
| 3691 | LGBS 0016 | kaiser | 04/03/2014 2:51:58 PM |
| 3690 | NXCP .0348 | kaiser | 04/03/2014 2:09:29 PM |
| 3689 | LGBS 0015 should have updates coming next | kaiser | 04/03/2014 2:07:56 PM |
| 3688 | NXCP .032 X .0348 | kaiser | 04/03/2014 1:50:50 PM |
| 3687 | MELY 0019 | kaiser | 04/03/2014 1:32:02 PM |
| 3686 | NXCP .03 X .033 nice bid in. Should be a nice | kaiser | 04/03/2014 1:31:32 PM |
| 3685 | MELY 0017 | kaiser | 04/03/2014 1:27:00 PM |
| 3684 | LRDR 0027 | kaiser | 04/03/2014 1:25:31 PM |
| 3683 | MELY 0015 | kaiser | 04/03/2014 1:24:15 PM |
| 3682 | MONA || @.0004 Breaking Out On Pending Merger ! | stockstock | 04/03/2014 12:47:05 PM |
| 3681 | $BMIN with over 1.2 million tons per year of iron | PurpleNinjaPanda | 04/03/2014 12:30:37 PM |
| 3680 | LRDR 0025 | kaiser | 04/03/2014 11:54:50 AM |
| 3679 | LRDR 002 | kaiser | 04/03/2014 11:47:40 AM |
| 3678 | LRDR 0019 | kaiser | 04/03/2014 11:46:21 AM |
| 3677 | LRDR 0017 should be a nice bounce play | kaiser | 04/03/2014 11:34:25 AM |
| 3676 | IDNG 0051 nice | kaiser | 04/03/2014 11:24:06 AM |
| 3675 | IDNG 0041 | kaiser | 04/03/2014 11:17:48 AM |
| 3674 | EHOS 0065 | kaiser | 04/03/2014 11:12:43 AM |
| 3673 | IDNG 0038 | kaiser | 04/03/2014 11:03:51 AM |
| 3672 | IDNG 0031 | kaiser | 04/03/2014 10:57:50 AM |
| 3671 | EHOS 0062 X 0065 | kaiser | 04/03/2014 10:52:59 AM |
| 3670 | MELY 0012 | kaiser | 04/03/2014 10:46:48 AM |
| 3669 | MELY 0011 | kaiser | 04/03/2014 10:43:29 AM |
| 3668 | APRU 0015 X 0016 | kaiser | 04/03/2014 10:41:55 AM |
| 3667 | IDNG 0029 | kaiser | 04/03/2014 10:40:03 AM |
| 3666 | APRU 0015 hitting | kaiser | 04/03/2014 10:39:36 AM |
| 3665 | MELY 001 | kaiser | 04/03/2014 10:16:28 AM |
| 3664 | IDNG 0028 | kaiser | 04/03/2014 10:16:09 AM |
| 3663 | IDNG 0027 | kaiser | 04/03/2014 10:12:37 AM |
| 3662 | IDNG 0026 | kaiser | 04/03/2014 10:10:19 AM |
| 3661 | MELY 0009 going | kaiser | 04/03/2014 10:09:55 AM |
Recent Articles
- Microsoft's Strategic Shift in AI Development and Ethics
- U.S.-China Trade Agreement: Impact on Economy and Relations
- Recent Trends in Large Cap Stocks: Key Market Movers
- Avidity Biosciences Announces Acquisition by Novartis AG Deal
- Legal Action Encouraged for Designer Brands Inc. Investors
- Exploring the Future of Kratom: Insights from Kratom Bird
- Novartis Enhances Neuroscience Pipeline Through Avidity Biosciences Acquisition
- EggNest™ System: A Breakthrough in Radiation Safety for Cath Labs
- Critical Importance of Court Reporting in High-Profile Trials
- Mark Cuban's Insight: Billionaires and Market Stability
- Blockchain Jungle 2025: Experience Innovation in Technology
- Fortinet Shareholders Urged to Join Securities Class Action
- Controversial $130 Million Donation to Pentagon Raises Concerns
- Fate Therapeutics: Advances in CAR T-Cell Therapy for Lupus
- JPMorgan Faces Legal Challenge Over Excessive Fraud Fees
- JPMorgan Fights $115 Million Legal Fees After Fraud Case
- Fate Therapeutics Unveils Promising Data on FT819 CAR T-Cell Therapy
- Baxter International, Inc. Faces Class Action Lawsuit Amid Losses
- ETC Mining Unveils Mobile App for Cloud Mining of XRP, BTC, ETH
- Top 5 Stocks Gaining Investor Interest for Future Growth
- Dow Inc. Class Action Lawsuit: Opportunities for Investors
- WPP Investors Urged to Participate in Securities Class Action
- Credit Blockchain Revolutionizes AI Integration in Crypto
- Semler Investors Face Class Action Deadline - Act Now!
- Urgent Alert for Dow Inc. Investors: Class Action Timeline Approaches
- Trump's Bold Strategy: A Revolutionary Shift in Mining
- LifeMD's Class Action Lawsuit: What Investors Need to Know
- Tech Giants Face New Challenges Amid Rivalry and Innovation
- America's Strategic Shift: Mining the Future of Resources
- MSP Miner's Innovative Cloud Mining Platform for Universal Access
- Celebrating Musical Excellence: Heida Hermanns Competition Event
- Essential Steps for LifeMD Inc. Investors Before Deadline
- Investors Encouraged to Review Claims Related to Savara Inc
- Navigating Disagreements: Jeff Bezos' Unique Leadership Style
- Investors Alert: Semler Scientific Faces Legal Investigation
- Investigation on Baxter International: An Investor's Insight
- Legal Update for V.F. Corporation Investors on Shareholder Action
- Investigating Quantifiable Losses for Quanex Building Products
- Investigation Launched into Marex Group Investor Claims
- Important Class Action Update for Quanex Building Products
- Cytokinetics Investigation: Legal Options for Shareholders
- Investigation Launched on Behalf of LifeMD Shareholders
- Tronox Holdings: Investors Urged to Join Class Action Suit
- Investors of Molina Healthcare Urged to Consider Legal Options
- Upcoming Legal Action for Jasper Therapeutics Investors Explained
- Investigation Into aTyr Pharma: Shareholder Losses Explored
- KBR Shareholder Insights: Investigating Investor Claims
- MoonLake Immunotherapeutics Shareholder Updates: Key Insights
- Investigating the Recent Decline of Tvardi Therapeutics Stock
- Investors Mobilize for WPP Class Action Amid Concerns
